Marc Gunther

Marc Gunther writes frequently about psychedelics. You can read his reporting at Medium and follow him on Twitter at @MarcGunther.

12 Articles Published | Follow:
Shifting Strategy, MAPS Turns to Equity Investment
Group Therapy Holds Promise for Psychedelic-Based Treatments
Gilgamesh Tweaks Known Psychedelics To Improve Therapies
Awakn Navigates the Tough Market for Investment Capital
Carey Turnbull Wears Many Hats as a Donor and Investor
What’s the Future of Eleusis Therapeutics After Acquisition by Beckley Psytech?
Eleusis Holdings Plans To Be Acquired By Beckley Psytech
As Plant-Medicine Churches Grow, Legal Questions Linger
Young Psychedelic Philanthropist Blazes Path for the Psychedelic Future
Can Psychedelics Treat Inflammation and Eye Disease? Eleusis Thinks So.